Wang et al. [56] elucidated phosphatase and tensin homolog (PTEN) role as a barrier for cancer progression, suggesting it as a therapeutic target for GC treatment; since PTEN loss or inactivation is linked to increased tumor aggressiveness and poor clinical outcomes in GC, restoring its function using gene therapy emerged as a promising strategy to combat the tumor’s progression. This evidence concerns the gene PTEN and cancer.